← Back to Search

Behavioral Intervention

Exposure, Relaxation, and Rescripting Therapy for Trauma Nightmares (ERRT Trial)

N/A
Recruiting
Led By Joanne L Davis, PhD
Research Sponsored by University of Tulsa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older at the time of the intake
Be older than 18 years old
Must not have
Unmedicated bipolar disorder
Age of 17 or younger
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months followup
Awards & highlights
No Placebo-Only Group

Summary

This trial is designed to study the efficacy of a brief treatment for chronic post-trauma nightmares by examining the dose effect and mechanism of change.

Who is the study for?
This trial is for adults who have experienced a traumatic event and suffer from frequent trauma-related nightmares, at least once weekly over the past month. Participants must be able to read and speak English. It's not suitable for individuals under 18, those with active suicidal thoughts, unmedicated bipolar disorder, recent substance abuse issues, psychosis, recent self-harm behaviors or intellectual disabilities.
What is being tested?
The study tests Exposure, Relaxation, and Rescripting Therapy (ERRT), a psychological treatment aimed at reducing the frequency and severity of post-trauma nightmares and improving sleep quality. The trial seeks to understand how different components of ERRT contribute to its effectiveness through weekly sessions lasting about 90 minutes each.
What are the potential side effects?
As ERRT is a form of psychotherapy focusing on exposure to traumatic memories in a controlled environment followed by relaxation techniques and cognitive restructuring, side effects may include temporary increases in distress or emotional discomfort during early stages of therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have bipolar disorder and am not taking medication for it.
Select...
I am 17 years old or younger.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months followup
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months followup for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Nightmare Frequency Past Week

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

5Treatment groups
Active Control
Group I: ERRT-SleepActive Control1 Intervention
Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced sleep techniques
Group II: ERRT - Enhanced ExposureActive Control1 Intervention
Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced exposure techniques
Group III: ERRT-RescriptionActive Control1 Intervention
Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with rescription but no exposure
Group IV: ERRT - Consensus ManualActive Control1 Intervention
Consensus Protocol, 6 sessions, includes components of ERRT and other nightmare protocols.
Group V: ERRT - Sleep and RelaxationActive Control1 Intervention
Exposure, Relaxation, and Rescripting Therapy protocol, 5 sessions, focused on sleep and relaxation

Find a Location

Who is running the clinical trial?

University of TulsaLead Sponsor
15 Previous Clinical Trials
5,051 Total Patients Enrolled
Joanne L Davis, PhDPrincipal InvestigatorUniversity of Tulsa
1 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

Exposure, Relaxation, and Rescripting Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02236377 — N/A
Post-traumatic stress disorder Research Study Groups: ERRT-Sleep, ERRT - Enhanced Exposure, ERRT-Rescription, ERRT - Consensus Manual, ERRT - Sleep and Relaxation
Post-traumatic stress disorder Clinical Trial 2023: Exposure, Relaxation, and Rescripting Therapy Highlights & Side Effects. Trial Name: NCT02236377 — N/A
Exposure, Relaxation, and Rescripting Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02236377 — N/A
~2 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top